Inspire Medical Systems (INSP) Stock Price, News & Analysis

Company Overview

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Key Stats

• Today's Range: $186.15 to $191.01
• 50-Day Range: $172.85 to $216.71
• 52-Week Range: $123.00 to $257.40
• Volume: 471,836 shs
• Average Volume: 598,307 shs
• Market Capitalization: $5.66 billion
• P/E Ratio: 176.38
• Dividend Yield: N/A
• Price Target: $233.58
• Consensus Rating: Moderate Buy

Inspire Medical Systems Stock Analysis - MarketRank™

Inspire Medical Systems scored higher than 95% of companies evaluated by MarketBeat, and ranked 74th out of 953 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Inspire Medical Systems has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 9 buy ratings, 3 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Inspire Medical Systems has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 49.62%

Earnings Growth

Earnings for Inspire Medical Systems are expected to grow by 49.62% in the coming year, from $1.33 to $1.99 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Inspire Medical Systems is 176.38, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 132.56.

Price to Earnings Ratio vs. Sector

The P/E ratio of Inspire Medical Systems is 176.38, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 105.71.

Price to Book Value per Share Ratio

Inspire Medical Systems has a P/B Ratio of 8.12. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

6.51% of the outstanding shares of Inspire Medical Systems have been sold short.

Short Interest Ratio / Days to Cover

Inspire Medical Systems has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Inspire Medical Systems has recently increased by 2.09%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Inspire Medical Systems does not currently pay a dividend.

Dividend Growth

Inspire Medical Systems does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 4.8 / 5
• Environmental Score: -0.66

Percentage of Shares Shorted

6.51% of the outstanding shares of Inspire Medical Systems have been sold short.

Short Interest Ratio / Days to Cover

Inspire Medical Systems has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Inspire Medical Systems has recently increased by 2.09%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 4.1 / 5
• News Sentiment: 1.38

News Sentiment

Inspire Medical Systems has a news sentiment score of 1.38. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 14 news articles for Inspire Medical Systems this week, compared to 9 articles on an average week.

Search Interest

7 people have searched for INSP on MarketBeat in the last 30 days. This is an increase of 75% compared to the previous 30 days.

MarketBeat Follows

4 people have added Inspire Medical Systems to their MarketBeat watchlist in the last 30 days. This is an increase of 33% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Inspire Medical Systems insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $182,665.00 in company stock.

Percentage Held by Insiders

Only 4.10% of the stock of Inspire Medical Systems is held by insiders.

Percentage Held by Institutions

94.91% of the stock of Inspire Medical Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

INSP Stock Analysis - Frequently Asked Questions

How have INSP shares performed this year?

Inspire Medical Systems' stock was trading at $203.43 at the start of the year. Since then, INSP shares have decreased by 7.2% and is now trading at $188.73.
View the best growth stocks for 2024 here.

How were Inspire Medical Systems' earnings last quarter?

Inspire Medical Systems, Inc. (NYSE:INSP) posted its quarterly earnings results on Monday, November, 4th. The company reported $0.60 earnings per share for the quarter, topping analysts' consensus estimates of $0.06 by $0.54. Inspire Medical Systems's revenue for the quarter was up 32.6% compared to the same quarter last year.

When did Inspire Medical Systems IPO?

Inspire Medical Systems (INSP) raised $75 million in an initial public offering (IPO) on Thursday, May 3rd 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs acted as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers.

Who are Inspire Medical Systems' major shareholders?

Top institutional shareholders of Inspire Medical Systems include FMR LLC (9.84%), Wellington Management Group LLP (4.65%), Baillie Gifford & Co. (4.58%) and Wasatch Advisors LP (4.42%). Insiders that own company stock include Timothy P Herbert, Marilyn C Nelson, Richard Buchholz, Shawn Mccormick, John Rondoni, Jerry C Griffin, Steven Jandrich, Randy Ban and Philip Ebeling.
View institutional ownership trends.

How do I buy shares of Inspire Medical Systems?

Shares of INSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Inspire Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Inspire Medical Systems investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), UnitedHealth Group (UNH), Tesla (TSLA), CrowdStrike (CRWD) and Johnson & Johnson (JNJ).

Company Calendar

• Last Earnings: 11/04/2024
• Today: 11/22/2024
• Fiscal Year End: 12/31/2024
• Next Earnings (Estimated): 2/04/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NYSE:INSP
• CUSIP: N/A
• CIK: 1609550
• Web: www.inspiresleep.com
• Phone: (844) 672-4357
• Fax: N/A
• Employees: 1,011
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $233.58
• High Stock Price Target: $260.00
• Low Stock Price Target: $197.00
• Potential Upside/Downside: +24.3%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.75
• Research Coverage: 12 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $1.07
• Trailing P/E Ratio: 175.56
• Forward P/E Ratio: 141.24
• P/E Growth: N/A
• Net Income: $-21,150,000.00
• Net Margins: 4.37%
• Pretax Margin: 4.90%
• Return on Equity: 5.30%
• Return on Assets: 4.58%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 7.84
• Quick Ratio: 6.94

Sales & Book Value

• Annual Sales: $755.59 million
• Price / Sales: 7.45
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $23.24 per share
• Price / Book: 8.08

Miscellaneous

• Outstanding Shares: 29,967,000
• Free Float: 28,738,000
• Market Cap: $5.63 billion
• Optionable: Optionable
• Beta: 1.36